Deutsche Bank Says Buy Valeant After 'Significant Change' Over Last Two Years
March 05, 2018 at 12:41 PM EST
Shares of Valeant Pharmaceuticals are on the rise after Deutsche Bank analyst Gregg Gilbert upgraded the stock to Buy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
